Últimas noticias sobre 2seventy bio (NASDAQ:TSVT) Bolsa

2seventy bio

2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment focusing on researching, developing and commercializing potentially transformative treatments for cancer.

2seventy bio Inc

<ul>
<li>VYVGART&#xAE; is first-and-only targeted IgG Fc-antibody fragment for CIDP</li>
<li>First novel mechanism of action for CIDP treatment in more than 30 years</li>
<li>CHMP positive opinion based on ADHERE data, the largest ever CIDP clinical trial</li>
<li>European Commission (EC) decision on marketing authorization application (MAA)&nbsp;expected within approximately two months</li>
</ul>

News

ARGX

argenx's VYVGART For CIDP Gains Positive CHMP Opinion Based On Data From ADHERE Clinical Trial

RVMD

Reported Sunday, Revolution Medicines Initial Phase 1 Study Data Show Zoldonrasib Achieves 61% Objective Response Rate in KRAS G12D Mutant NSCLC

Ace investor and fund manager, Cathie Wood, is doubling down on Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), reaffirming her confidence in the company's ability to lead the enterprise AI race, as shifting market dynamics disrupt established players in this space.
What Happened: On Saturday, the Ark Invest CEO quoted a post on X by Brett Winton, the firm's chief futurist, who simply wrote, "Excel. Will. Die." The post predicts the eventual downfall of Microsoft Corp.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) widely used spreadsheet software, which has been a mainstay in office environments for decades.
See More: <a href="https://www.benzinga.com/news/25/04/45019174/palantir-stock-soars-on-defense-deals-whats-going-on">Palantir Stock Soars On Defense Deals: What&#8217;s Going On?</a>
In response to the post, Wood questioned how Microsoft and its enterprise clients would navigate the &#8220;massive disruption,&#8221; before saying, &#8220;Palantir comes to mind.&#8221; 
According to Wood, Palantir CEO Alex Karp believes that the company will become the largest pure-play enterprise AI software company in the world, &#8220;I believe him,&#8221; she says.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I wonder how <a href="https://twitter.com/search?q=%24MSFT&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$MSFT</a> and its enterprise clients are going to manage through this massive disruption. Palantir comes to mind. CEO Alex Karp believes that <a href="https://twitter.com/search?q=%24PLTR&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$PLTR</a> will become the largest pure play enterprise AI software company in the world. I believe him. <a href="https://t.co/pFJxPueKdn">https://t.co/pFJxPueKdn</a>
&mdash; Cathie Wood (@CathieDWood) <a href="https://twitter.com/CathieDWood/status/1916166595593805966?ref_src=twsrc%5Etfw">April 26, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Palantir is now Ark Invest's <a href="https://cathiesark.com/ark-funds-combined/complete-holdings">second-largest holding</a> after Tesla, with a stake valued at $640 million, representing about 7% of its total assets under management across its family of funds.
Microsoft has made significant headway in enterprise AI, with the segment already sporting a <a href="https://benzinga.com/markets/equities/25/01/43327008/microsofts-13-billion-run-rate-and-openai-azure-deal-spark-surge-in-enterprise-demand-for-ai-solutions-just-first-tranche-of-future-growth-potential">$13 billion annual run rate</a>, a figure that is nearly 5 times Palantir&#8217;s annual revenue in 2024. However, the latter is gaining ground rather quickly and is already pulling ahead in sectors such as defense. 
While Microsoft continues to pursue cloud dominance, <a href="https://benzinga.com/trading-ideas/technicals/25/04/44947382/palantir-rolls-out-tanks-microsoft-builds-clouds-whos-winning-ais-next-frontier">Palantir is inking partnerships</a> with major defense contractors and is in the process of building a futuristic AI-powered tank. 
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td class="has-text-align-center" data-align="center">Stock / ETF</td>
<td class="has-text-align-center" data-align="center">YTD Performance</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>)</td>
<td class="has-text-align-center" data-align="center">-6.39%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>)</td>
<td class="has-text-align-center" data-align="center">+49.99%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Ark Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#BATS">ARKK</a>)</td>
<td class="has-text-align-center" data-align="center">-10.35%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Ark Space Exploration &amp; Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKX#BATS">ARKX</a>)</td>
<td class="has-text-align-center" data-align="center">-4.89%</td>
</tr>
</tbody>
</table>
</figure>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="141" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28012832/Screenshot-2025-04-28-at-10.58.18-AM-1024x141.png" alt="" class="wp-image-890106" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28012832/Screenshot-2025-04-28-at-10.58.18-AM-1024x141.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28012832/Screenshot-2025-04-28-at-10.58.18-AM-300x41.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28012832/Screenshot-2025-04-28-at-10.58.18-AM-768x106.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28012832/Screenshot-2025-04-28-at-10.58.18-AM-1536x211.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28012832/Screenshot-2025-04-28-at-10.58.18-AM.png 1616w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Palantir scores remarkably well on Benzinga&#8217;s Stock Edge Rankings, with a strong price trend in the short, medium, and long terms, but how does it compare with Microsoft? Sign up for <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge</a> to find out.
Photo courtesy: slyellow / Shutterstock.com
Read More: <a href="https://www.benzinga.com/25/04/45031447/elon-musk-says-the-best-human-surgeons-have-just-five-years-before-robots-overtake-them-reveals-instance-when-neuralink-had-to-use-a-robot-for-task-impossible-for-a-human">Elon Musk Says Best Human Surgeons Will Be Outdone By Robots In Almost 5 Years, Cites Example Of His Own Brain-Chip Company</a>

Markets

ETFs

ARKK

ARKX

MSFT

PLTR

Cathie Wood Sees Palantir Dominating Enterprise AI, Wonders How Microsoft Will Manage 'Massive Disruption' — Will Excel Finally Die?

<ul>
<li>Data suggest potential for superior tumor selectivity, potent efficacy, and improved safety profile</li>
<li>Abpro and Celltrion have a strategic partnership for worldwide development and commercialization of ABP-102/CT-P72</li>
<li>HER2-positive cancers represent up to 30 percent of all cases of breast, gastric, pancreatic, colorectal and other forms of cancer</li>
</ul>

Reported Sunday, Abpro And Celltrion Present Preclinical Data For ABP-102/CT-P72, Showcasing Potential Best-In-Class HER2 X CD3 T-Cell Engager

President Donald Trump vowed Sunday to "bring Columbus Day back from the ashes." 
What Happened: Trump pledged on Truth Social to restore the federal holiday "under the same rules, dates, and locations" it held for decades. 
"The Democrats did everything possible to destroy Christopher Columbus, his reputation, and all of the Italians that love him so much," he wrote, adding that statues toppled during racial-justice protests would see a "major comeback."
Trump's declaration reignites a long-running culture clash over the second Monday in October. In 2021, former President Joe Biden became the first sitting president to <a href="https://bidenwhitehouse.archives.gov/briefing-room/presidential-actions/2021/10/08/a-proclamation-indigenous-peoples-day-2021/">issue a proclamation</a> recognizing Indigenous Peoples Day, noting the "resilience and strength" of Native communities and the "systematic" federal policies that once sought to erase them. Many cities and states have since replaced or paired Columbus Day with observances honoring Indigenous history.
See also: <a href="https://www.benzinga.com/markets/25/04/45030778/trump-running-american-economy-like-a-mafia-don-economist-craig-shapiro-draws-parallels-with-russias-president">Trump Running American Economy Like A &#8216;Mafia Don&#8217;: Economist Craig Shapiro Draws Parallels With Russia&#8217;s President</a>
During his first term, Trump routinely praised Columbus as a symbol of exploration, saying in a <a href="https://trumpwhitehouse.archives.gov/presidential-actions/presidential-proclamation-columbus-day-2018/">2018 proclamation</a> that the navigator's voyage "formed the initial bond between Europe and the Americas, and changed the world forever." He never referenced Indigenous Peoples Day.
Why It Matters: Trump's promise to elevate Columbus Day fits in with his broader campaign against what he calls "woke" initiatives, from scrapping federal <a href="https://www.benzinga.com/25/03/44344917/trumps-ban-on-dei-programs-allowed-for-now-by-appeals-court">diversity-equity programs</a> to <a href="https://www.benzinga.com/25/04/44804541/trump-administration-halts-2-2-billion-in-harvard-grants-after-university-says-dont-dictate-what-we-can-teach-or-who-we-admit">threatening to pull funds</a> from universities that adopt policies he opposes. The former president has repeatedly criticized teaching U.S. history through themes of oppression and race, casting his holiday push as another salvo in that culture war.
Ironically, Columbus Day itself was conceived as a tribute to diversity, <a href="https://apnews.com/article/trump-columbus-indigenous-peoples-day-biden-ee34f1873a9af8ea85ac732b9edf82fc">according</a> to the Associated Press. Lawmakers embraced the explorer in the late 19th century to court Italian-American voters as immigration from Italy surged. Columbus never reached the future United States, but his Genoese roots offered a convenient symbol for newcomers seeking acceptance — and for politicians eager to win their support.
Photo Courtesy: Rawpixel.com on Shutterstock.com
Read next: <a href="https://www.benzinga.com/25/04/45031652/trumps-ai-and-crypto-czar-david-sacks-says-musk-isnt-out-of-doge-just-rationing-his-time-at-the-department-as-tesla-stock-surges-24-in-the-past-five-days">Trump&#8217;s AI And Crypto Czar David Sacks Says Elon Musk Going To &#8216;Stay Involved&#8217; In DOGE, Calls Entrepreneur Rationing His Time Sensible</a>

Government

Regulations

Events

Trump Vows To Bring Back Columbus Day 'From The Ashes,' Promises To Restore 'Same Rules, Dates And Locations'

<ul>
<li>Long-term data from the Volt&nbsp;CE Mark Study show strong results out to 12 months in patients receiving pulsed field ablation (PFA) therapy with the Volt&#x2122; PFA System</li>
<li>The 12-month results of the Volt&nbsp;CE Mark Study confirm the long-term safety and efficacy of the Volt PFA System</li>
<li>The data were presented at the 2025 Heart Rhythm Society (HRS) annual meeting</li>
</ul>

Reported Saturday, Abbott Presents New Volt PFA System Data Highlighting Outstanding Long-Term Safety And Freedom From Arrhythmia At 12 Months

<ul>
<li>Late-breaking data from Abbott's groundbreaking first-in-human study demonstrated successful implantation of the company's AVEIR Conduction System Pacing (CSP) leadless pacemaker</li>
<li>Enrollment has also begun in the ASCEND CSP pivotal clinical trial to evaluate Abbott's investigational CSP Implantable Cardioverter-Defibrillator (ICD) lead</li>
<li>Conduction System Pacing is an evolving technique specifically designed to deliver pacing to the left bundle branch area of the heart to restore its natural electrical rhythm</li>
</ul>

Reported Sunday, Abbott's AVEIR CSP Study Demonstrates First Successful Leadless Conduction System Pacing In Left Bundle Branch Area

YMAB

Reported Sunday, Y-mAbs Highlights Preclinical And Translational PK Modeling Of CD38-SADA Bispecific Fusion Protein At AACR 2025

URGN

Reported Sunday, UroGen Highlights Nearly Four-Year Duration Of Response In OLYMPUS Long-Term Follow-Up Study Of JELMYTO

<ul>
<li>New analysis of patient-reported outcomes from the OPTIMA II, ATLAS and ENVISION studies of UGN-102 presented at the American Urological Association (AUA) 2025 Annual Meeting in Las Vegas, Nevada</li>
</ul>

Reported Sunday, UroGen Presents New Data Showing UGN-102 Does Not Adversely Affect Functionality or Symptom Burden

Reported Sunday, UroGen's OPTIMA II Study Results Show UGN-102 Delivers Median 24.2-Month Duration Of Response In Recurrent LG-IR-NMIBC

<ul>
<li>18-month DOR of 80.6% by Kaplan-Meier estimate was attained in patients who achieved a complete response (CR) at three months (79.6%)</li>
<li>Data unveiled during a Podium Presentation at the American Urological Association (AUA) 2025 Annual Meeting in Las Vegas, Nevada</li>
</ul>

Reported Saturday, UroGen Pharma's UGN-102 Achieves 80.6% Probability Of Sustained Complete Response At 18 Months In Phase 3 ENVISION Trial

<ul>
<li>UGN-301 was tolerated across all dose levels, with no dose-limiting toxicities or adverse events leading to treatment discontinuation</li>
<li>UGN-301 formulated in a reverse thermal gel allowed sustained exposure in the bladder</li>
<li>Some patients receiving UGN-301 (zalifrelimab) intravesical solution showed clinical activity at the week 12 disease assessment</li>
<li>Data presented at the 2025 American Urological Association Annual Meeting in Las Vegas, Nevada</li>
</ul>

Reported Saturday, UroGen Pharma's UGN-301 Phase 1 Trial Shows Sustained Bladder Exposure And No Dose-Limiting Toxicities In Non-Muscle Invasive Bladder Cancer

Nuveen California Dividend Advantage Municipal Fund 2

Reported Earlier, NOVONIX Names Michael O'Kronley CEO, Effective May 19

IOTR

Reported Earlier, iO3's F.R.I.D.A.Y Planned Maintenance System Secures ClassNK Approval, Paving Way For Maritime Digitalization

Last Tuesday, Elon Musk revealed that he is shifting focus from the Department of Government Efficiency to Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>). The announcement sent the <a href="https://www.benzinga.com/markets/25/04/45029648/tesla-stock-skyrockets-20-following-elon-musks-return-and-shift-from-doge">automaker's stock soaring</a> nearly 24% in the past five days. Now, Donald Trump's AI and crypto czar, David Sacks, has offered insight into Musk's management strategy.
What Happened: During <a href="https://www.benzinga.com/news/earnings/25/04/44937440/tesla-q1-misses-estimates-as-tariff-pressures-weigh-on-outlook-lower-cost-evs-still-on-track">Tesla's first-quarter earnings</a> call, Musk said that he would significantly reduce his time commitment to DOGE, dedicating only one to two days per week moving forward.
Over the weekend, in an episode of the All-in Podcast, Sacks explained that Musk isn't entirely stepping away from DOGE but rather streamlining his efforts to better balance his many responsibilities.
&#8220;I saw this before when I was part of the Twitter transition,&#8221; Sacks explained, adding that for the first three months, Musk dedicated intense bursts of time to get the right people in place and then shifted to a maintenance mode.
&#8220;He&#8217;s going to stay involved, but as an SGE [Special Government Employee], he&#8217;s limited to 130 days a year anyway, and so it makes sense for him to kind of now ration his days a little more closely,&#8221; referring to the <a href="https://www.benzinga.com/25/03/44557947/doge-blowback-aside-elon-musk-considers-tesla-a-solid-opportunity">Tesla CEO&#8217;s role at DOGE</a>.
See Also: <a href="https://www.benzinga.com/tech/25/04/44941657/elon-musk-equates-car-ownership-in-future-to-riding-a-horse-while-using-a-flip-phone-pierre-ferragu-says-teslas-iphone-moment-hinges-on-full-autonomy">Elon Musk Equates Car Ownership In Future To Riding A Horse While Using A Flip Phone — Pierre Ferragu Says Tesla&#8217;s &#8216;iPhone Moment&#8217; Hinges On Full Autonomy</a>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Trump Rally or Bessent Put? Elon Back at Tesla, Google&#039;s Gemini Problem, China&#039;s Thorium Discovery" width="500" height="281" src="https://www.youtube.com/embed/4tcd1EgQrhU?start=3940&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Why It's Important: Tesla&#8217;s first-quarter revenue reached $19.34 billion, a 9% drop from the same period last year. This figure fell short of Wall Street&#8217;s expectations, missing the $21.35 billion consensus estimate.
Following Musk's announcement about significantly reducing time at DOGE, Daniel Ives from Wedbush Securities responded positively and <a href="https://www.benzinga.com/25/04/44945402/wedbushs-dan-ives-raises-teslas-price-target-to-350-as-musk-promises-to-significantly-reduce-doge-time">raised Tesla's price target</a> to $350 per share.
However, not all analysts were optimistic about Tesla&#8217;s earnings. Ross Gerber expressed growing skepticism about Musk's ambitious projections. Gerber called it the <a href="https://www.benzinga.com/markets/25/04/44941889/teslas-sweet-little-lies-hide-worst-performance-ever-elon-musks-robot-takeover-talk-is-just-a-smokescreen-says-ross-gerber">worst performance he has seen</a> in his 11 years of covering the company.
Price Action: Tesla&#8217;s shares have risen by 23.73% over the past five days. However, despite this gain, the stock is still down 24.87% year-to-date, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
According to Benzinga Edge Stock Rankings, Tesla currently holds a growth score of 45.57%. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Click here to see how it compares</a> to other companies in the sector.
Photo courtesy: Joshua Sukoff / Shutterstock.com
Read Next:
<ul>
<li><a href="https://benzinga.com/25/04/44855242/charlie-munger-once-highlighted-how-warren-buffetts-lifelong-learning-made-berkshire-hathaways-success-possible-and-the-crucial-lesson-you-can-take-from-it" target="_blank" rel="noreferrer noopener">Charlie Munger Once Said Warren Buffett Is A ‘Learning Machine' And That's What Lies Beneath Berkshire Hathaway's Success From One Decade To Another</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Tech

TSLA

Trump's AI And Crypto Czar David Sacks Says Elon Musk Going To 'Stay Involved' In DOGE, Calls Entrepreneur Rationing His Time Sensible

Faraday Future Intelligent Electric Inc. - Class A Common Stock

FFAI

Reported Earlier, Faraday Future Receives Powerful Endorsements From California Leaders Backing FX Brand, Bridge Strategy, And YT Jia's Co-CEO Appointment

At the closing of this transaction, Airbus will take ownership of the following Spirit assets:
<ul>
<li>the site of Kinston, North Carolina, U.S. (A350 fuselage sections);</li>
<li>the site of St. Nazaire, France (A350 fuselage sections);</li>
<li>the site of Casablanca, Morocco (A321 and A220 components);</li>
<li>the production of components for the A320 and A350 wings in Prestwick, Scotland;</li>
<li>the production of A220 pylons in Wichita, Kansas, U.S.;</li>
<li>the production of A220 wings in Belfast, Northern Ireland; and</li>
<li>if a suitable buyer is not identified for the remainder of the Belfast site, the production of the A220 mid-fuselage.</li>
</ul>
The assets in Subang, Malaysia related to Airbus programs will also be acquired by Airbus if no suitable buyer is identified before the closing of the transaction.

European Aeronautic Defence And Space Unsponsored

EADSY

Spirit AeroSystems Announces Asset Divestiture To Airbus Ahead Of Boeing Company Acquisition Closing

Elon Musk says the surgical scalpel is about to lose its top billing to algorithms and actuators, predicting "robots will surpass good human surgeons within a few years and the best human surgeons within ~5 years."
What Happened: Replying to tech commentator Mario Nawfal's post on X touting robot-run operating rooms, Musk added that Neuralink "had to use a robot for the brain-computer electrode insertion, as it was impossible for a human to achieve the required speed and precision."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Robots will surpass good human surgeons within a few years and the best human surgeons within ~5 years. <a href="https://twitter.com/neuralink?ref_src=twsrc%5Etfw">@Neuralink</a> had to use a robot for the brain-computer electrode insertion, as it was impossible for a human to achieve the required speed and precision. <a href="https://t.co/ipPhQK8z1j">https://t.co/ipPhQK8z1j</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1916573094367625556?ref_src=twsrc%5Etfw">April 27, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Neuralink's R1 machine places 64 hair-thin threads into the cortex in about 15 minutes, steering past blood vessels with micron-level accuracy, according to the company's hardware blog and earlier public demos.​ The robot is now part of the <a href="https://neuralink.com/blog/prime-study-progress-update/">PRIME human trial</a> testing the N1 wireless implant in patients with paralysis.​
See also: <a href="https://www.benzinga.com/tech/25/04/44969594/jeff-bezos-final-ceo-letter-isnt-just-about-amazon-it-was-a-clarion-call-for-resisting-normality-the-world-wants-you-to-be-typicaldont-let-it-ha">Jeff Bezos&#8217; Final CEO Letter Isn&#8217;t Just About Amazon — It Is A Clarion Call For Resisting Normality: &#8216;The World Wants You To Be Typical…Don&#8217;t Let It Happen&#8217;</a>
Musk's timeline lands as autonomous systems notch real-world wins. Johns Hopkins' Smart Tissue Autonomous Robot recently stitched pig intestines with <a href="https://hub.jhu.edu/2022/01/26/star-robot-performs-intestinal-surgery/">leak-free precision</a> that matched or beat experienced surgeons.​ A January study cited by Reuters even found robots reduced complications in complex liver procedures versus open surgery.​
Even semi-autonomous platforms are surging: Intuitive Surgical says its surgeon-controlled da Vinci systems have logged nearly 17 million procedures worldwide.​ Peer-reviewed analyses report that algorithm-guided suturing and screw placement now outperform human averages for accuracy and consistency.​
Why It Matters: Musk isn&#8217;t the only one backing humanoid robots to replace skilled hospital doctors. Bill Gates, in a recent chat, mentioned that he foresees robots with dexterous &#8220;hands&#8221; <a href="https://www.benzinga.com/tech/25/04/44857520/bill-gates-says-his-kids-and-grandkids-will-live-in-a-very-changed-world-as-ai-puts-an-end-to-shortage-of-teachers-and-doctors">making it routine</a> to staff hospitals, adding that he&#8217;s certain that his kids and grandkids will live in a &#8220;very changed world&#8221;.
Meanwhile, Musk also believes Neuralink will <a href="https://www.benzinga.com/general/biotech/25/04/44892867/elon-musk-says-neuralink-will-help-blind-people-see-again-will-exceed-the-best-human-eyes">help restore vision</a> for the "completely blind," pointing to early milestones such as implant recipient Noland Arbaugh, who now <a href="https://www.benzinga.com/news/25/03/44358022/paralyzed-man-moves-objects-with-his-mind-thanks-to-elon-musks-brain-chip">controls a computer cursor</a> with his thoughts. The bold promise has drawn skeptics, including former White House strategist Steve Bannon, who recently <a href="https://www.benzinga.com/general/biotech/25/04/44891849/steve-bannon-says-elon-musk-is-evil-blasts-his-brain-chip-ambitions-as-technofeudalist-plot-to-hijack-humanitys-future">blasted Musk and Neuralink</a> in an interview.
Photo Courtesy: Frederic Legrand &#8211; COMEO On Shutterstock.com
Read next: <a href="https://www.benzinga.com/25/04/45030694/openai-ceo-sam-altman-says-gpt-4o-personality-tweaks-made-it-annoying-fixes-coming-this-week">Sam Altman Admits ChatGPT New Upgrade Made It Too Sycophantic And Annoying: OpenAI CEO Says &#8216;Working On Fixes ASAP&#8217;</a>

General

Elon Musk Says Best Human Surgeons Will Be Outdone By Robots In Almost 5 Years, Cites Example Of His Own Brain-Chip Company

The global cryptocurrency market capitalization stands at $2.93 trillion, showing a 1.04% decrease over the last day. Bitcoin&#8216;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) market dominance currently sits at 63.39%, reflecting a slight 0.01% daily decline.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Gains +/-</td>
<td>Price (Recorded at 10.55 p.m. ET)</td>
</tr>
<tr>
<td>Bitcoin</td>
<td>-0.73%</td>
<td>$93,601.76</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>-2.16%</td>
<td>$1,774.17</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>-1.12%</td>
<td>$0.1761</td>
</tr>
</tbody>
</table>
</figure>
Trading activity intensified with 97,249 traders liquidated for $176.13 million over 24 hours, as open interest fell 4.62% to $117.06 billion and liquidations rose 2.59% to $175.92 million, Coinglass data shows.
The Crypto Fear &amp; Greed Index remains at a neutral reading of 54, indicating balanced market sentiment.
Traditional markets closed positively on Friday, with the Dow Jones Industrial Average, tracked by SPDR Dow Jones Industrial Average ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>), gaining 0.05% to 40,113.50, the S&amp;P 500 tracked by SPDR S&amp;P 500 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rising 0.74% to 5,525.21, and the Nasdaq-100 tracked by Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) advancing 1.14% to 19,432.56.
Futures linked to the Dow Jones Industrial Average dropped 60 points, or 0.1%. S&amp;P 500 futures declined by 0.2%, while Nasdaq 100 futures fell 0.2%.
Top Gainers (24-Hours)
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Gains</td>
<td>Price (Recorded at 10.55 p.m. ET)</td>
</tr>
<tr>
<td>Pudgy Penguins (PENGU)</td>
<td>+24.07%</td>
<td>$0.0121</td>
</tr>
<tr>
<td>DeepBook Protocol (DEEP)</td>
<td>+19.18</td>
<td>$0.2071</td>
</tr>
<tr>
<td>Walrus (WAL)</td>
<td>+18.04%</td>
<td>$0.6419</td>
</tr>
</tbody>
</table>
</figure>
Investors will closely monitor this week&#8217;s critical economic events, including the first estimate of the first quarter of 2025 U.S. GDP growth, which analysts <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44520487/negative-gdp-growth-is-more-likely-than-not-in-q1-economist-warns">expect to show significant slowing</a>. 
The jobs report, personal consumption expenditures inflation data, and the Institute for Supply Management Purchasing Managers&#8217; Index will also be in focus. 
Additionally, earnings reports from major tech companies like Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), and Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) could influence broader market sentiment.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/45029413/peter-schiff-questions-trumps-bitcoin-ambition-amid-trade-deficit-concerns-resources-are-just-wasted">Peter Schiff Questions Trump&#8217;s Bitcoin Ambition Amid Trade Deficit Concerns: &#8216;Resources Are Just Wasted&#8217;</a>
Analyst Notes:&nbsp; Prominent cryptocurrency analyst Willy Woo noted on X that &#8220;BTC fundamentals have turned bullish,&#8221; providing a favorable environment to break all-time highs. Woo highlighted increasing capital flows into the network, with both total and speculative flows bottoming out. 
&#8220;All dips are for buying under the present regime,&#8221; Woo summarized, though cautioning that Bitcoin&#8217;s short-term movement may be limited due to overextension.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">BTC fundamentals have turned bullish, not a bad setup to break all time highs. I took a break from X to enjoy the NZ summer but every week I put out a series of analysis to my subscribers (this is a hobby, NOT a long term project). Thought I&#39;d post this update publicly.
&mdash; Willy Woo (@woonomic) <a href="https://twitter.com/woonomic/status/1916359463910707450?ref_src=twsrc%5Etfw">April 27, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Meanwhile, analyst Michaël van de Poppe said that altcoins are turning bullish after &#8220;the longest bear market ever,&#8221; which lasted four years. 
Van de Poppe emphasized the correlation between Chinese Renminbi/U.S. Dollar movements and Ethereum&#8217;s performance against Bitcoin, suggesting that macroeconomic factors are more influential than traditional four-year crypto cycles.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Altcoins?src=hash&amp;ref_src=twsrc%5Etfw">#Altcoins</a> Turn Bull after Longest Bear Market It&#39;s been an absolutely horrific bear markets for altcoins and a lot of expectations have crushed in the past quarter. I&#39;ve spend all my time figuring out what has happened. Indicators show green. Let&#39;s discuss them &#x2b07;&#xFE0F; First of… <a href="https://t.co/E7uDXK8gpB">pic.twitter.com/E7uDXK8gpB</a>
&mdash; Michaël van de Poppe (@CryptoMichNL) <a href="https://twitter.com/CryptoMichNL/status/1916471668005814510?ref_src=twsrc%5Etfw">April 27, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto analyst Ali Martinez said that Bitcoin&#8217;s &#8220;Accumulation Trend Score is nearing 1, signaling intense accumulation and strong holder conviction.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> Accumulation Trend Score is nearing 1, signaling intense accumulation and strong holder conviction. <a href="https://t.co/Y8LaGiroXz">pic.twitter.com/Y8LaGiroXz</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1916584636009885988?ref_src=twsrc%5Etfw">April 27, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The cryptocurrency market continues its maturation process amid growing institutional adoption, with U.S. Securities and Exchange Commission Chair Paul Atkins recently calling for clearer regulatory frameworks to <a href="https://www.benzinga.com/25/04/45028954/cryptocurrencies-surge-bitcoin-mining-costs-soar-sec-chair-calls-for-clear-crypto-regulations-this-week-in-crypto">help the industry thrive in the United States</a>.
Shutterstock: Yalcin Sonat
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/45030998/dogecoin-millionaire-says-give-a-serious-thought-to-floki-as-memecoin-makes-impressive-30-gains-over-7-days-asks-followers-to-strap-in">Dogecoin &#8216;Millionaire&#8217; Says Give A &#8216;Serious&#8217; Thought To Floki As Memecoin Makes Impressive 30% Gains Over 7 Days, Asks Followers To &#8216;Strap In&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

$BTC

$DOGE

$ETH

AAPL

AMZN

SPDR Dow Jones Industrial Average ETF Trust

Bitcoin, Ethereum, Dogecoin Drop As Stock Futures Slide: Willy Woo Says 'All Dips Are For Buying' With BTC Eyeing 'All-Time Highs

Press Releases

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of 2seventy bio, Inc.

Shareholder Alert: The Ademi Firm investigates whether 2seventy bio, Inc. is obtaining a Fair Price for its Public Shareholders

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of 2seventy bio, Inc. - TSVT

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TSVT, BRDG, GB on Behalf of Shareholders

2SEVENTY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 2seventy bio, Inc. - TSVT

Comments

2seventy bio

Noticias

Últimas noticias sobre 2seventy bio (NASDAQ:TSVT) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL